Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drorit Neumann

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2007
An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturationOrly Ravid, Imad Shams, Nathalie Ben Califa, et al.
Organic Letters|September 11, 2008
Taumycins A and B, two bioactive lipodepsipeptides from the Madagascar sponge Fascaplysinopsis spAshgan Bishara, Amira Rudi, Maurice Aknin, et al.
European Journal of Haematology|February 14, 2004
Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studiesMoshe Mittelman, Aliza Zeidman, Pazit Kanter, et al.
The Israel Medical Association Journal : IMAJ|November 28, 2006
Erythropoietin in clinical practice: current use, effect on survival, and future directionsHoward S Oster, Michael Hoffman, Sara Prutchi-Sagiv, et al.
FEBS Letters|May 9, 2002
Amino acid residues 268-276 of the erythropoietin receptor contain an endocytosis motif and are required for erythropoietin-mediated proliferationGalit Flint-Ashtamker, Ronit Eisen-Lev, Jacob Cohen, et al.
Marine Drugs|November 29, 2013
Derivatives of salarin A, salarin C and tulearin A--Fascaplysinopsis sp. metabolitesLee Goren Zur, Ashgan Bishara, Maurice Aknin, et al.
Oncogene|April 30, 2025
Immunomodulatory function of cannabinoid receptor 2 and its agonist osteogenic growth peptide in health and cancer: a study in mice and humansJennifer Ana Iden, Nathalie Ben-Califa, Aaron Naim, et al.
Scientific Reports|August 3, 2016
Erythropoietin treatment in murine multiple myeloma: immune gain and bone lossNaamit Deshet-Unger, Sahar Hiram-Bab, Yasmin Haim-Ohana, et al.
Leukemia Research|April 21, 2009
Non-erythroid effects of erythropoietin: are neutrophils a target?Maayan Avneon, Lilach Lifshitz, Odelia Katz, et al.
Organic Letters|July 25, 2009
Tausalarin C: a new bioactive marine sponge-derived nitrogenous bismacrolideAshgan Bishara, Amira Rudi, Israel Goldberg, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2007
An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturationOrly Ravid, Imad Shams, Nathalie Ben Califa, et al.
Organic Letters|September 11, 2008
Taumycins A and B, two bioactive lipodepsipeptides from the Madagascar sponge Fascaplysinopsis spAshgan Bishara, Amira Rudi, Maurice Aknin, et al.
European Journal of Haematology|February 14, 2004
Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studiesMoshe Mittelman, Aliza Zeidman, Pazit Kanter, et al.
The Israel Medical Association Journal : IMAJ|November 28, 2006
Erythropoietin in clinical practice: current use, effect on survival, and future directionsHoward S Oster, Michael Hoffman, Sara Prutchi-Sagiv, et al.
FEBS Letters|May 9, 2002
Amino acid residues 268-276 of the erythropoietin receptor contain an endocytosis motif and are required for erythropoietin-mediated proliferationGalit Flint-Ashtamker, Ronit Eisen-Lev, Jacob Cohen, et al.
Marine Drugs|November 29, 2013
Derivatives of salarin A, salarin C and tulearin A--Fascaplysinopsis sp. metabolitesLee Goren Zur, Ashgan Bishara, Maurice Aknin, et al.
Oncogene|April 30, 2025
Immunomodulatory function of cannabinoid receptor 2 and its agonist osteogenic growth peptide in health and cancer: a study in mice and humansJennifer Ana Iden, Nathalie Ben-Califa, Aaron Naim, et al.
Scientific Reports|August 3, 2016
Erythropoietin treatment in murine multiple myeloma: immune gain and bone lossNaamit Deshet-Unger, Sahar Hiram-Bab, Yasmin Haim-Ohana, et al.
Leukemia Research|April 21, 2009
Non-erythroid effects of erythropoietin: are neutrophils a target?Maayan Avneon, Lilach Lifshitz, Odelia Katz, et al.
Organic Letters|July 25, 2009
Tausalarin C: a new bioactive marine sponge-derived nitrogenous bismacrolideAshgan Bishara, Amira Rudi, Israel Goldberg, et al.
Pageof 6